• Godawari Power & Ispat is mainly engaged in the business of Mining Iron Ore and Manufacturing Iron Ore Pellets, Sponge Iron, Steel Billets, Wire Rods, H.B. Wire and Ferro Alloys with the generation of Electricity. The company has two captive mines- Ari Dongri Mine & Boria Tibu Mine. GPIL sources 85% of its iron ore needs captively from its mines(Chattisgarh) for the production of steel and has its own captive power generation facility too. Its capacity includes 3.05 MT of Iron Ore Mining, 2.7 MT of Iron Ore Pellets, 0.594 MT of Sponge Iron and 0.525 MT of Steel Billets and Fabrication and Galvanizing plant of 0.11 MT.
• In the fiscal year concluding on March 31, 2024, the company achieved turnover totalling Rs. 54.55 bn. As of 9th May 2024 company has a total net worth of Rs.44..96 cr
The company has approved the proposal for the buyback of Equity Shares at a price of Rs.1400/- per equity share up to an aggregate amount not exceeding Rs. 3.01 bn from the shareholders of the Company on a proportionate basis through a tender offer.
In the dynamic landscape of financial strategies, Zydus Lifesciences Ltd. has recently announced a buyback of shares in the year 2024. This strategic move has sparked intrigue within the investment community, prompting both shareholders and potential investors to delve into the intricacies of this significant development.
CMP (Rs) | 1136 |
Buy Back Price (Rs) | 1400 |
Acceptance Ratio* | 4.74% |
Total no. of share to be bought | 21,50,000 |
Total no of equity share | 135944988 |
Buyback % of total equity share | 1.58% |
Reserved for Retail* quota (15%) | 3,22,500 |
Max share retail investor can buy^ | 142 |
Record date | 28th June 2024 |
BB Code | GPIL IN EQUITY |
---|---|
ISIN | INE177H01021 |
52 WKH(Rs.) | 1179.95 |
52 WKL(Rs | 461.60 |
Market Cap {INR Bn) | 1156.20 |
March-24 | Dec-23 | Sep-23 | |
---|---|---|---|
Promoters | 63.26 | 63.26 | 63.26 |
FII's | 5.54 | 5.41 | 4.66 |
DII's(Rs | 2.08 | 2.09 | 1.52 |
Public | 29.12 | 29.23 | 30.56 |
No. of Shares to Buy* | Total investment @ Rs.1136.35 | Acceptance Ratio(%) | Buyback no shares | Value of accepated share via buy Buyback price share value at Rs.1400 | Left over Shares | Profit/loss scenario post Buyback if client sell remaining share | |||
---|---|---|---|---|---|---|---|---|---|
At Rs.1071 | At Rs.1190 | At Rs.1323 | At Rs.1470 | ||||||
142 | 1,61,362 | 5 | 7.0 | 9,800 | 135 | -4.32% | -5.63% | 16.76% | 29.06% |
142 | 1,61,362 | 10 | 14 | 19,600 | 128 | -2.90% | 6.54% | 17.09% | 28.75% |
142 | 1,61,362 | 15 | 21.0 | 29,400 | 121 | -1.47% | 7.45% | 17.43% | 28.45% |
142 | 1,61,362 | 20 | 28.0 | 39,200 | 114 | -0.04% | 8.37% | 17.76% | 28.15% |
142 | 1,61,362 | 30 | 42.0 | 58,800 | 100 | 2.81% | 10.19% | 18.43% | 27.54% |
142 | 1,61,362 | 40 | 56.0 | 78,400 | 86 | -5.67% | 12.01% | 19.10% | 26.93% |
142 | 1,61,362 | 50 | 71.0 | 99,400 | 71 | 8.73% | 13.96% | 19.81% | 26.28% |
Source: Company, CEBPL
Note:
*Actual acceptance ratio may vary,
^Assume stock price reached Rs.1005 on ex-date,
#round down to nearest integer
* Retail shareholders holding less than Rs 2 Lac shares as on “Record Date”
* Please note acceptance Ratio is Dynamic in Nature can be change on Record date
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.